Clinical Trial Update: Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stellate ganglion block to augment trauma-focused therapy for veterans with PTSD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder
• Trauma- and Stressor-related Disorders

Snippet

Sponsor: Ohio State University | Conditions: PTSD, Trauma and Stressor Related Disorders | Phase 2 | Status: COMPLETED